These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32935659)

  • 21. Reducing bloodstream infection with a chlorhexidine gel IV dressing.
    Jeanes A; Bitmead J
    Br J Nurs; 2015 Oct 22-Nov 11; 24(19):S14-9. PubMed ID: 26496869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
    Timsit JF; Mimoz O; Mourvillier B; Souweine B; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Lepape A; Vesin A; Arrault X; Schwebel C; Adrie C; Zahar JR; Ruckly S; Tournegros C; Lucet JC
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1272-8. PubMed ID: 23043083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
    Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
    J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
    Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
    Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gauze and tape and transparent polyurethane dressings for central venous catheters.
    Webster J; Gillies D; O'Riordan E; Sherriff KL; Rickard CM
    Cochrane Database Syst Rev; 2011 Nov; (11):CD003827. PubMed ID: 22071809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients.
    Biehl LM; Huth A; Panse J; Krämer C; Hentrich M; Engelhardt M; Schäfer-Eckart K; Kofla G; Kiehl M; Wendtner CM; Karthaus M; Ullmann AJ; Hellmich M; Christ H; Vehreschild MJ
    Ann Oncol; 2016 Oct; 27(10):1916-22. PubMed ID: 27456299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    de Campos Pereira Silveira RC; Dos Reis PED; Ferreira EB; Braga FTMM; Galvão CM; Clark AM
    Support Care Cancer; 2020 Feb; 28(2):425-438. PubMed ID: 31493134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
    Crawford AG; Fuhr JP; Rao B
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
    Jenks M; Craig J; Green W; Hewitt N; Arber M; Sims A
    Appl Health Econ Health Policy; 2016 Apr; 14(2):135-49. PubMed ID: 26458938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
    Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
    Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a chlorhexidine-impregnated dressing reduced catheter-related bloodstream infections caused by Gram-positive microorganisms.
    Ergul AB; Gokcek I; Ozcan A; Cetin S; Gultekin N; Torun YA
    Pak J Med Sci; 2018; 34(2):347-351. PubMed ID: 29805406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biofilm Formation on Central Venous Catheters: A Pilot Study.
    Niemann B; Dudas L; Gray D; Pettit A; Wilson A; Bardes JM
    J Surg Res; 2022 Dec; 280():123-128. PubMed ID: 35964484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales.
    Fraser C; Harron K; Dalton L; Gilbert R; Oddie SJ;
    PLoS One; 2018; 13(11):e0204894. PubMed ID: 30383769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
    Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
    Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.